Fosun International LTD Protagonist Therapeutics, Inc Transaction History

Fosun International LTD

  • $106 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019
SELL
$9.41 - $16.56 $447,097 - $786,815
-47,513 Closed
0 $0
Q1 2019

May 10, 2019
SELL
$6.5 - $13.77 $318,500 - $674,730
-49,000 Reduced 50.77%
47,513 $585,000
Q4 2018

Jan 31, 2019
BUY
$6.3 - $10.44 $608,031 - $1.01 Million
96,513 New
96,513 $609,000

Others Institutions Holding PTGX

# of Institutions
248
Shares Held
56.7M
Call Options Held
76.3K
Put Options Held
114K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $1.93B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Fosun International LTD Portfolio

Follow Fosun International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email